(T 04) Patient Treatment Satisfaction With OnabotulinumtoxinA Versus Topiramate for Chronic Migraine

Presenting Author(s)

Andrew M. Blumenfeld, MD

Faculty neurologist
Cedars Sinai
Los Angeles, California, United States

TP

Tae Jin Park, PharmD

Associate Director, HEOR
AbbVie
North Chicago, IL, United States
TC

Tsz “Tiffany” Chan, PharmD

AbbVie, United States
IS

Iryna Shakhmantsir, PhD

Scientific Director
AbbVie
North Chicago, Illinois, United States
JR

John F. Rothrock, MD

University of Virginia School of Medicine, United States